KSE
Search
- Page Path
- HOME > Search
Original Article
- Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses
- Chelim Cheong, Tae-Jin Lee
- Epidemiol Health. 2014;36:e2014012. Published online August 14, 2014
- DOI: https://doi.org/10.4178/epih/e2014012
- 17,513 View
- 153 Download
- 14 Web of Science
- 14 Crossref
-
Abstract
PDF -
AbstractOBJECTIVES
Despite the clinical and epidemiological importance of herpes zoster (HZ) and postherpetic neuralgia (PHN), their disease and economic burden related to immune status has not been studied in South Korea. Our aim was to calculate the prevalence and rate of healthcare utilization related to HZ and PHN among Korean patients stratified by immune status.METHODSThis retrospective study used the Health Insurance Review and Assessment Service National Patients Sample (HIRA K-NPS) database, which includes all medical claims from January to December 2009 on a representative sample of the Korean population. HZ and PHN patients aged ≥ 50 years were categorized into three groups by immune status: severely immunocompromised group, moderately compromised group, and non-compromised group. The prevalence, disease-related healthcare utilization, and medical costs were compared across the three groups.RESULTSWe estimated that there were 312,136 HZ patients and 48,461 PHN patients ≥ 50 years in South Korea. The prevalence of HZ and PHN was 18.54 and 2.88 per 1,000 persons, respectively, and increased with deteriorating immune status. The number of outpatient visits and hospitalization rate among HZ patients were highest in the severely immunocompromised group (4.38% and 7.52%, respectively) and lowest in the non-compromised group (3.82% and 4.08%, respectively). The average medical cost per patient in the severe group was the highest (240 US dollars) and that of the non-compromised group was the lowest (161 US dollars). No parameters were significantly different among patients with PHN by immunity.CONCLUSIONSHZ patients with severe immunodeficiency had a higher prevalence of HZ, more outpatient visits and hospitalizations, longer hospitalizations, and higher medical costs than their counterparts did. Efforts should be made to reduce the HZ-related burden of severely immunocompromised patients. -
Summary
Citations
Citations to this article as recorded by
- Prevalence and healthcare utilization in managing herpes zoster in primary care: a retrospective study in an Asian urban population
Xin-Bei Valerie Chan, Ngiap Chuan Tan, Mark Chung Wai Ng, Ding Xuan Ng, Yi Ling Eileen Koh, Wai Keong Aau, Chirk Jenn Ng
Frontiers in Public Health.2023;[Epub] CrossRef - Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study
Jing Chen, Ju-Young Shin, Sumitra Shantakumar, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Iain Kaan
Infectious Diseases and Therapy.2023; 12(12): 2771. CrossRef - Thinking Outside the Tooth
Akihiro Ando, Phuu P. Han, Seena Patel
Dental Clinics of North America.2022; 66(2): 229. CrossRef -
Longdan
X
iegan formula as adjuvant therapy for acute herpes zoster: A meta‐analysis of randomized controlled trials
Luxia Zhang, Aijun Duan, Yanfeng Li, Jing Feng
Dermatologic Therapy.2022;[Epub] CrossRef - Chondromalacia patella increases the risk of herpes zoster: a population-based study
Chia-Hung Chen, Yung-Chi Cheng, Hsin-Yi Yang, Ching-Fang Tsai, Chao-Yu Hsu, Der-Shin Ke, Wen-Che Hsieh
BMC Musculoskeletal Disorders.2022;[Epub] CrossRef - Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
Sarah A Buchan, Nick Daneman, Jun Wang, Gary Garber, Anne E Wormsbecker, Sarah E Wilson, Shelley L Deeks
Clinical Infectious Diseases.2020; 71(1): 22. CrossRef - Asthma increases the risk of herpes zoster: a nested case–control study using a national sample cohort
So Young Kim, Dong Jun Oh, Hyo Geun Choi
Allergy, Asthma & Clinical Immunology.2020;[Epub] CrossRef - Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study
João Toniolo-Neto, Eliofotisti Psaradellis, Angela Karellis, Emmanouil Rampakakis, Talita Y. Rockett, John S. Sampalis, Kelly D. Johnson, Homero A. Monsanto, Camilo J. Acosta
Clinics.2018; 73: e243. CrossRef - Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific
Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou, Samsuridjal Djauzi, Birong Dong, Taro Kojima, Ki Tae Kwon, Hoe Nam Leong, Edward M. F. Leung, Chih-Kuang Liang, Xiaohong Liu, Dilip Mathai, Jiun Yit Pan, Li-Ning Peng, Eduardo Rommel S. Poblet
BMC Infectious Diseases.2017;[Epub] CrossRef - Incidence of herpes zoster amongst adults varies by severity of immunosuppression
Carsten Schröder, Dirk Enders, Tania Schink, Oliver Riedel
Journal of Infection.2017; 75(3): 207. CrossRef - Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States
Juliana L. Meyers, Shweta Madhwani, Debora Rausch, Sean D. Candrilli, Girishanthy Krishnarajah, Songkai Yan
Human Vaccines & Immunotherapeutics.2017; 13(8): 1861. CrossRef - Association between Treatment with Biologic Agents and the Incidence of Herpes Zoster in Rheumatoid Arthritis
Doo-Ho Lim, Yong-Gil Kim
Journal of Rheumatic Diseases.2017; 24(5): 251. CrossRef - The Epidemiology of Myasthenia Gravis in Korea
Hyung Seok Lee, Hye Sun Lee, Ha Young Shin, Young-Chul Choi, Seung Min Kim
Yonsei Medical Journal.2016; 57(2): 419. CrossRef - Higher prevalence of dementia in patients with schizophrenia: A nationwide population‐based study
Hyemin Ku, Eui‐Kyung Lee, Kyoung‐Uk Lee, Min‐Young Lee, Jin‐Won Kwon
Asia-Pacific Psychiatry.2016; 8(2): 145. CrossRef
First
Prev
